Nobel-winning UK scientist launches programme to develop hepatitis C vaccine in Hong Kong
A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug-makers. Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C…
Full story
Read the full story at South China Morning Post ↗
Continue reading this story on South China Morning Post, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
